Scholar
IQ
Help
Try ScholarIQ free
Home
Papers
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
Upload Records
Snowball Search
Search OpenAlex
About the database
ScholarIQ
answers from OpenAlex
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
Paper
Citations, authors & open-access status
3,407
Citations
2,013
Year
bronze
OA Status
IDs:
DOI
PMID
OpenAlex
Related on ScholarIQ
Omid Hamid
Author
Jeffrey S. Weber
Author
Jedd D. Wolchok
Author
Wen-Jen Hwu
Author
Caroline Robert
Author
Christine Mateus
Author
470M+ articles · free account